Pink Sheet

UK Wants European Court's View On Paroxetine Pay-For-Delay Case

28 Mar 2018

A referral in the long-running paroxetine pay-for-delay case will see the Court of Justice of the EU give preliminary rulings on a number of competition issues such as abuse of a dominant position, the relevant product market, and restrictions of competition by object and by effect.

Question mark — The UK has referred some questions on the paroxetine pay-for-delay case to the CJEU.

The long-running UK proceedings concerning alleged pay-for-delay deals on generic paroxetine have moved up a notch after the Competition Appeal Tribunal referred a number of questions regarding competition and patent infringement issues to the Court of Justice of the EU.

The referrals were made after the CAT examined a total of five appeals by GlaxoSmithKline and a number of...